The present invention relates to novel cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases, preferably p38 kinase. They are useful in the treatment of inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.

 
Web www.patentalert.com

< Dendritic enriched secreted lymphocyte activation molecule

< Regulation of endogenous gene expression in cells using zinc finger proteins

> Antiviral pyrimidinedione derivatives and process for the preparation thereof

> Human ovarian mesothelial cells and methods of isolation and uses thereof

~ 00245